Skip to main content
OpenTrials
Completed

NCT Number: NCT01869452

Platform Therapeutic Education in Heart Failure and Coronary Disease

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Acute Coronary Syndrome Cardiovascular Diseases Coronary Bypass Graft Stenosis of Native Artery Graft Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinique Turin, Paris, France

Loading trial locations.

About this study

Patients are assigned to an arm accordingly to their needs: class 1 with light therapeutic education, class 2 with moderate education, class 3 with heavy education. Assignement is based on the first education diagnosis during hospitalization time.

Quality of life and patient's knowledge are regularly evaluated through questionnaires

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina)
  • hospitalization for heart failure
  • acute coronary syndrome < 3 months
  • heart failure < 3 months
  • coronary by-pass surgery < 3 months

Exclusion criteria

  • complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock)
  • valvular cardiac pathology
  • obstructive cardiomyopathy
  • planned cardiac transplantation
  • severe neurological or psychiatric troubles
  • loss of autonomy
  • other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)

Treatment and study plan

Therapeutic education

Behavioral

knowledge of disease, risk factors, diet, medication, alert symptoms

Primary outcomes

  1. number of patient with a better of quality of life

    Time frame: 1 year

    quality of life is evaluated with appropriate questionnaires

Secondary outcomes

  1. number of patients who improve their knowledge of disease

    Time frame: 1 year

    Knowledge of disease includes risk factors, symptoms, medication, diet. It is evaluated with appropriate questionnaires.

  2. number of hospitalizations during the follow up

    Time frame: 1 year

    hospitalizations are recorded during the year of follow up, with cause and duration.

Sponsors and collaborators

Lead sponsor

Resicard

Other

Collaborators

  • union nationale de formation et d'evaluation en medecine cardio-vasculaire

Registry information

Official study title

Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease

Acronym: METISCARDIO

Important dates

Study start
2010
Primary completion
2013
Study completion
2014
First posted
Jun 5, 2013
Registry last updated
May 5, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.